TRIDEM Pharma

Tridem Pharma, is a French company created in 1986, specialized in the distribution of drugs, medical promotion and regulatory affairs, a subsidiary of the FOSUN PHARMA group since December 2017. It operates in the African and Middle Eastern markets. It has established a comprehensive pharmaceutical supply chain that covers nearly 90% of the Africa region. In 1986, TRIDEM Pharma began to gain solid experience in these markets. Acting as an expert interface between the major players in the pharmaceutical industry and the markets of French-speaking and English-speaking Africa and the Middle East (health authorities, wholesalers, prescribers and pharmacists), its activity is dedicated to the supply of pharmaceuticals, dermo-cosmetics and in vitro diagnostics (IVD) and rapid diagnostic tests, in compliance with the most demanding pharmaceutical and logistical Quality standards (Good Pharmaceutical Distribution Practices). Thanks to its reputation, its image of excellence and the unique global market access solution it offers (medical promotion, distribution, regulatory affairs and pharmacovigilance), it has a portfolio of clients wishing to develop their presence. in African and Middle Eastern markets. His multiple areas of expertise are factors of success for his clients.

PharmaCare Laboratories

PharmaCare is one of the largest Australian-owned health, wellness and consumer goods companies in the country. An Australian-born and built success story, PharmaCare is dedicated to enriching people’s lives through improved health and wellness. Despite its products being available globally, its soul is Australian, its quality is Australian, and its spirit of honesty, hard work and entrepreneurial drive is Australian. PharmaCare’s trusted, household brands include Sambucol, Nature’s Way, Bioglan, Medi+, Ease-a-Cold, Skin Doctors, KP24, Brut, Norsca, Bounce and many more. Our global wheelhouse of brands is available in 40 countries, over 5,200 pharmacies, 3,000 supermarkets, plus department and variety stores all over Australia, New Zealand, Asia, The America's and Europe.

MMS

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com

Advarra

Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.

Merz Therapeutics

At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics is headquartered in Frankfurt am Main, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.